Literature DB >> 12386229

Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system.

.   

Abstract

Mesh：

Year:  2002        PMID： 12386229     DOI： 10.1093/ndt/17.suppl_7.63

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  25 in total

Review 1.  [Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  M Schmitz; M Joannidis; D Czock; S John; A Jörres; S J Klein; M Oppert; V Schwenger; J Kielstein; A Zarbock; D Kindgen-Milles; C Willam
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-08       Impact factor: 0.840

2.  Safety and efficacy of heparin during dialysis in the context of systemic anticoagulant and antiplatelet medications.

Authors:  Steven M Brunelli; Dena E Cohen; Gilbert Marlowe; Daniel Liu; Levi Njord; David Van Wyck; George Aronoff
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

Review 3.  Anticoagulation in CKD and ESRD.

Authors:  Kelvin Cheuk-Wai Leung; Jennifer Marie MacRae
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

Review 4.  Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.

Authors:  Jenny I Shen; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2012-05-05       Impact factor: 8.860

Review 5.  Clinical review: use of renal replacement therapies in special groups of ICU patients.

Authors:  Eric A J Hoste; Annemieke Dhondt
Journal:  Crit Care       Date:  2012-01-19       Impact factor: 9.097

6.  Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.

Authors:  Karlien François; Karl Martin Wissing; Rita Jacobs; Dries Boone; Kristine Jacobs; Christian Tielemans
Journal:  BMC Nephrol       Date:  2014-07-03       Impact factor: 2.388

7.  Section 5: Dialysis Interventions for Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

8.  Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.

Authors:  Patrick Rossignol; Marc Dorval; Renaud Fay; Joan Fort Ros; Nathalie Loughraieb; Frédérique Moureau; Maurice Laville
Journal:  Trials       Date:  2013-06-01       Impact factor: 2.279

9.  Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended?

Authors:  Edward Zimbudzi
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-04-15

Review 10.  Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).

Authors:  Norbert Lameire; John A Kellum
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.